Notable Labs Ltd (NTBLQ)

Currency in USD
0.020
0.000(0.00%)
Closed·
NTBLQ Scorecard
Full Analysis
Stock generally trades with high price volatility
NTBLQ is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0180.020
52 wk Range
0.0010.666
Key Statistics
Prev. Close
-
Open
0.018
Day's Range
0.018-0.02
52 wk Range
0.001-0.666
Volume
-
Average Volume (3m)
71.68K
1-Year Change
-96.78%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NTBLQ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Notable Labs Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Notable Labs Ltd Company Profile

Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and enables fast-track therapeutic development in this patient population. The company’s pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor to induce cell cycle arrest and apoptosis in various cancer cells; and Fosciclopirox to treat acute myeloid leukemia. It has a license agreement with Oncoheroes to develop and commercialize volasertib for cancers not licensed to the Company. Notable Labs, Ltd. is based in Foster City, California. On October 13, 2024, Notable Labs, Ltd. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware. It is in joint administration with Notable Labs, Inc.

Compare NTBLQ to Peers and Sector

Metrics to compare
NTBLQ
Peers
Sector
Relationship
P/E Ratio
0.0x−4.7x−0.5x
PEG Ratio
0.00−0.010.00
Price/Book
0.0x2.1x2.6x
Price / LTM Sales
0.0x9.5x3.2x
Upside (Analyst Target)
0.0%171.3%41.7%
Fair Value Upside
Unlock9.7%6.1%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-- / -0.79
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

NTBLQ Income Statement

FAQ

What Stock Exchange Does Notable Labs Trade On?

Notable Labs is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Notable Labs?

The stock symbol for Notable Labs is "NTBLQ."

What Is the Notable Labs Market Cap?

As of today, Notable Labs market cap is 193.19K.

What Is Notable Labs's Earnings Per Share (TTM)?

The Notable Labs EPS (TTM) is -1.42.

When Is the Next Notable Labs Earnings Date?

Notable Labs will release its next earnings report on 10 Aug 2025.

From a Technical Analysis Perspective, Is NTBLQ a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Notable Labs Stock Split?

Notable Labs has split 1 times.

How Many Employees Does Notable Labs Have?

Notable Labs has 16 employees.

What is the current trading status of Notable Labs (NTBLQ)?

As of 26 Jul 2025, Notable Labs (NTBLQ) is trading at a price of 0.02, with a previous close of 0.00. The stock has fluctuated within a day range of 0.02 to 0.02, while its 52-week range spans from 0.00 to 0.67.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.